The Boulder, Colo.-based start-up is advertising a machine that can let researchers design and make small amounts of new organisms. Financiers in the round include previous and new investors like Paladin Capital Group, JS Capital Management, Oak HC/FT and Venrock.”Biology has unlimited capacity to positively alter this world,” states Kevin Ness, the chief executive of Inscripta.

The Boulder, Colo.-based startup is advertising a machine that can let researchers design and manufacture small quantities of brand-new organisms. It’s a technology that financiers are falling over themselves to finance. Financiers in the round consist of previous and new investors like Paladin Capital Group, JS Capital Management, Oak HC/FT and Venrock.”Biology has limitless potential to favorably alter this world,” says Kevin Ness, the chief executive of Inscripta.